0 false false false false false false false false false false true false false true true true true No description of principal activity 2022-09-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 12807681 2022-09-01 2023-08-31 12807681 2023-08-31 12807681 2022-08-31 12807681 2021-09-01 2022-08-31 12807681 2022-08-31 12807681 2021-08-31 12807681 bus:RegisteredOffice 2022-09-01 2023-08-31 12807681 bus:LeadAgentIfApplicable 2022-09-01 2023-08-31 12807681 bus:Director1 2022-09-01 2023-08-31 12807681 bus:Director2 2022-09-01 2023-08-31 12807681 core:WithinOneYear 2023-08-31 12807681 core:WithinOneYear 2022-08-31 12807681 core:ShareCapital 2023-08-31 12807681 core:ShareCapital 2022-08-31 12807681 core:RetainedEarningsAccumulatedLosses 2023-08-31 12807681 core:RetainedEarningsAccumulatedLosses 2022-08-31 12807681 bus:SmallEntities 2022-09-01 2023-08-31 12807681 bus:AuditExemptWithAccountantsReport 2022-09-01 2023-08-31 12807681 bus:SmallCompaniesRegimeForAccounts 2022-09-01 2023-08-31 12807681 bus:PrivateLimitedCompanyLtd 2022-09-01 2023-08-31 12807681 bus:FullAccounts 2022-09-01 2023-08-31
COMPANY REGISTRATION NUMBER: 12807681
HEALTH INVESTMENTS (POOLE) LIMITED
FILLETED UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED
31 August 2023
HEALTH INVESTMENTS (POOLE) LIMITED
FINANCIAL STATEMENTS
YEAR ENDED 31 AUGUST 2023
Contents
Page
Officers and professional advisers
1
Statement of financial position
2
Notes to the financial statements
3
HEALTH INVESTMENTS (POOLE) LIMITED
OFFICERS AND PROFESSIONAL ADVISERS
The board of directors
G Marsden
M Pendower
Registered office
Lynton House
7-12 Tavistock Square
London
WC1H BQ
Accountants
TC BSG Valentine Limited
Accountants
Lynton House
7-12 Tavistock Square
London
WC1H 9BQ
HEALTH INVESTMENTS (POOLE) LIMITED
STATEMENT OF FINANCIAL POSITION
31 August 2023
2023
2022
Note
£
£
£
£
CURRENT ASSETS
Stocks
922,034
918,284
Debtors
4
4,090
580
Cash at bank and in hand
12,013
6,292
---------
---------
938,137
925,156
CREDITORS: amounts falling due within one year
5
( 931,069)
( 926,035)
---------
---------
NET CURRENT ASSETS/(LIABILITIES)
7,068
( 879)
-------
----
TOTAL ASSETS LESS CURRENT LIABILITIES
7,068
( 879)
-------
----
NET ASSETS/(LIABILITIES)
7,068
( 879)
-------
----
CAPITAL AND RESERVES
Called up share capital
100
100
Profit and loss account
6,968
( 979)
-------
----
SHAREHOLDERS FUNDS/(DEFICIT)
7,068
( 879)
-------
----
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 August 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 9 February 2024 , and are signed on behalf of the board by:
M Pendower
Director
Company registration number: 12807681
HEALTH INVESTMENTS (POOLE) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 31 AUGUST 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Lynton House, 7-12 Tavistock Square, London, WC1H BQ.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Debtors
2023
2022
£
£
Trade debtors
3,990
Other debtors
100
580
-------
----
4,090
580
-------
----
5. Creditors: amounts falling due within one year
2023
2022
£
£
Trade creditors
52
1,380
Corporation tax
1,635
Social security and other taxes
27
Other creditors
929,355
924,655
---------
---------
931,069
926,035
---------
---------